Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adverse Drug Reactions
Study results from K.L. Krol and colleagues in the area of adverse drug reactions published
March 9th, 2008
New investigation results, 'Clinical evaluation of the Zilver vascular stent for symptomatic iliac artery disease,' are detailed in a study published in Journal of Vascular and Interventional Radiology. In this recently published article, scientists in the United States conducted a study "To evaluate the safety and effectiveness of the Zilver vascular stent in the treatment of de novo or restenotic lesions in the external and common iliac arteries. Regardless of the results of an initial percutaneous transluminal angioplasty (PTA), 151 consecutive patients were implanted with Zilver vascular stents (Cook, Bloomington, Ind) in up to two stenotic (<or=10 cm) or occluded (<or=5...
Source: Pharma Investments, Ventures & Law Weekly (2008-03-09)
|
